RS
RaySearch Laboratories AB (publ)
RSLBF · OTC
$17.74 +0.00% (+$0.00)
1M +7.52%
Market Cap 6.00B kr
P/E Ratio 28.19x
Div. Yield 2.45%
ROE 22.83%
Bulios Fair Price
$17.79
0.3% upside
Current Price
$17.74
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RSLBF is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
44 /100
Fair EV/EBITDA 14.96x
P/S 4.73x
P/B 7.67x
Growth
88 /100
Growing Rev. growth 16.80%
FCF growth 8.25%
Book val. growth 14.45%
Profitability
94 /100
Strong Net margin 16.78%
Op. margin 20.30%
FCF margin 22.36%
Quality
87 /100
Excellent ROE 22.83%
ROA 11.81%
Asset turnover 0.70x
Debt
90 /100
Low Current ratio 1.29x
Int. coverage 49.97x
Net debt/EBITDA 0.35x
Stability
65 /100
Moderate Rev. volatility 4.20%
EPS volatility 117.12%
Profitable years 4
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RSLBF
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Johan Lof
Employees
433
Headquarters
Stockholm
Upcoming events
03 NOV
Earnings
Upcoming earnings report